BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast

  July 22, 2016

   · 

  1 min read
• Octapharma AG To Sponsor Two Symposia At The 2016 World Federation Of Hemophilia (WFH) World Congress In Orlando, USA

  July 22, 2016

   · 

  1 min read
• Bio NC

  Heat Biologics Announces Suspension Of Proposed Public Offering Of Common Stock

  July 22, 2016

   · 

  2 min read
• Business

  Retrophin To Report Second Quarter 2016 Financial Results

  July 22, 2016

   · 

  1 min read
• Business

  Sequenom Schedules Second Quarter Results Conference Call For August 3, 2016

  July 22, 2016

   · 

  2 min read
• Pharm Country

  Mylan Publishes Supplement To Meda Offer Document

  July 22, 2016

   · 

  11 min read
• Biotech Bay

  European CHMP Adopts Positive Opinion On Gilead’s Type II Variation Application For Truvada For Reducing The Risk Of Sexually Acquired HIV

  July 22, 2016

   · 

  4 min read
• Pharm Country

  Citron Pharma Launches Rosuvastatin Calcium Tablets

  July 22, 2016

   · 

  2 min read
• Drug Development

  Puma Biotech Announces Interim 5-Year Disease Free Survival Data From Phase III Trial Of PB272 (Neratinib) In Extended Adjuvant HER2-Positive Early Stage Breast Cancer (Extenet Trial)

  July 22, 2016

   · 

  7 min read
• Policy

  Puma Biotech Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer

  July 22, 2016

   · 

  3 min read